Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
ABC Top Stories
Subscribe To This Feed

Marvel Studios

(HOLLYWOOD) -- Marvel's Avengers are assembling on ABC's Jimmy Kimmel Live! all next week.

To coincide with the release of the new movie Avengers: Infinity War, Kimmel will welcome a huge chunk of the cast from April 23 through Friday, April 27, when the film finally hits theaters. 

It's not clear which actors will appear on which days, but the lineup includes Robert Downey Jr., Tom Holland, Zoe Saldana, Pom Klementieff, Paul Bettany, Scarlett Johansson, Tom Hiddleston, Dave Bautista, Mark Ruffalo, Danai Gurira, Chris Hemsworth, Josh Brolin, Sebastian Stan, Chadwick Boseman, Karen Gillan, Benedict Cumberbatch, Don Cheadle, Elizabeth Olsen, and Winston Duke.

Too many names for you? You know them better as Iron Man, Spider-Man, Gamora, Mantis, Vision, Natasha "Black Widow" Romanoff, Loki, Drax, Bruce "The Hulk" Banner, Okoye, Thor, Thanos, Bucky "Winter Soldier" Barnes, Black Panther, Nebula, Dr. Strange,  Rhodey "War Machine" Rhodes, Wanda "Scarlet Witch" Maximoff, and M'Baku. 

Amazingly, that isn't even the entire cast of the superhero-stuffed film, which features all the characters from the last 10 years of Marvel movies coming together to defeat the Big Bad, Thanos, who wants to bring balance to the universe by wiping out half its inhabitants.

Jimmy Kimmel Live!  airs at 11:35 p.m. ET on ABC.  Avengers: Infinity War is from Marvel and Disney, parent company of ABC News.

Copyright © 2018, ABC Radio. All rights reserved.


Subscribe To This Feed

ABC News(WASHINGTON) -- The Justice Department on Thursday turned over to Congress declassified copies of former FBI director James Comey's memos - his contemporaneous notes about his conversations and encounters with President Donald Trump before he was fired last year.

The 15-page disclosure includes Comey's account of the briefing he gave Trump at Trump Tower about some of the allegations about his contacts with Russia, as well as his later meetings with Trump at the White House, during one in which Comey said that the president asked him for his loyalty and in another in which Comey says Trump told him: “I hope you can see your way clear to letting this go, to letting Flynn go.”

Comey says he took that as the president wanting him to end the investigation into retired Lt. Gen. Michael Flynn, Trump’s fired former national security adviser.

Comey also said that then-chief of staff Reince Priebus asked him whether Flynn was under government surveillance and that Trump claimed Russian President Vladimir Putin told him Russia had "some of the most beautiful hookers in the world."

Trump, who has previously dismissed the memos as "fake," claimed on Thursday night that the memos exonerated him in the ongoing Russia investigation while criticizing Comey's conduct.

You can read the declassified and partially redacted memos HERE.

Copyright © 2018, ABC Radio. All rights reserved.


Subscribe To This Feed

Fort Worth Star-Telegram/TNS via Getty Images(NEW YORK) -- Intelligence gathered over the past 18 months suggests that American journalist Austin Tice is still alive almost six years after he went missing in Syria, ABC News has learned.

The assessment comes as the FBI has, for the first time, announced a new reward for information leading to Tice's safe location, recovery, and return — for $1 million.

Two senior officials recently confirmed to ABC News that Tice, a journalist, and photographer kidnapped in August 2012, is believed to have survived his captivity despite past U.S. intelligence assessments that he might have died in Syria. A former Marine, Tice had been freelancing for several news outlets, including CBS and the Washington Post, and covering the start of the Syrian civil war.

 For a long time, the FBI only had one special agent assigned to the case – a person who had been serving in the bureau for less time than Tice had been missing. Some officials privately criticized the FBI for chasing old leads in the case and not devoting more resources to recovering him from what was assessed to be an element of Syrian dictator Bashar al Assad’s regime or his family.

By contrast, American hostages of terrorist groups such as Kayla Mueller killed in ISIS captivity, and Caitlan Coleman, who was freed last fall after five years as a Taliban hostage, had teams of FBI agents working their cases. One senior official told ABC News that there were intelligence officers augmenting the FBI’s work and that criticism of their efforts was unfair.

Tice, who would be 36-years old now, disappeared just after his 31st birthday while covering the Free Syrian Army, a group of Syrian military officials who had joined the opposition against Assad. A month later, a video was released, showing him blindfolded, removed from a car, and led by armed men up a hill, saying "Oh, Jesus." He has not been heard from since.

In December 2016, Sen. John Cornyn, R-Texas, said on the Senate floor that then-U.S. hostage envoy James O'Brien had informed him that Tice was alive.

"Mr. O'Brien and his team informed me that they have high confidence that Austin is alive in Syria along with other Americans who are being held captive," Cornyn said at the time.

The next month, Tice's parents said the Obama administration also told them, "Austin, our son, is alive, that he's still being held captive in Syria."

A current U.S. official confirmed recently that the assessment that he is alive has not changed.

Copyright © 2018, ABC Radio. All rights reserved.


Subscribe To This Feed

Scott Olson/Getty Images(NEW YORK) -- Some passengers on the Southwest Airlines flight that experienced a deadly engine failure this week told ABC News they received money and the promise of a travel voucher from the airline.

Southwest Flight 1380 experienced engine failure about 20 minutes after takeoff Tuesday from New York City's LaGuardia International Airport en route to Dallas Love Field. A woman who was partially sucked out of a window on the jet near the failed engine later died.

In a letter to passengers obtained by ABC News, the airline offered sincere apologies as well as a $5,000 check and the promise of a $1,000 travel voucher. The letter also states that the airline’s primary focus now is to assist the passengers who were aboard the flight in every way possible.

A Southwest Airlines official confirmed to ABC News that the letters were sent by the airline, but would not comment on the monetary gift.

“Ours is a company and culture built on relationships," the company said in a statement. "Many of the customers on that flight have flown with us before.”

The National Transportation Safety Board and the Federal Aviation Administration are investigating Tuesday's incident. Boeing said it is providing technical help to the investigation, with which Southwest Airlines is cooperating.

Copyright © 2018, ABC Radio. All rights reserved.


Subscribe To This Feed

iStock/Thinkstock(NEW YORK) -- Here are the scores from Wednesday's sports events:

 Final  Detroit      13  Baltimore    8
 Final  Houston       9  Seattle      2
 Final  N-Y Yankees   4  Toronto      3
 Final  Boston        8  L-A Angels   2
 Final  Chi Cubs       8  St. Louis       5
 Final  Philadelphia   7  Pittsburgh      0
 Final  Atlanta       12  N-Y Mets        4
 Final  Milwaukee     12  Miami           3
 Final  Arizona        3  San Francisco   1
 Final  Philadelphia  128  Miami        108
 Final  New Orleans   119  Portland     102
 Final  Golden State  110  San Antonio   97
 Final  Boston       3  Toronto    1
 Final  Washington   4  Columbus   1

Copyright © 2018, ABC Radio. All rights reserved.


Subscribe To This Feed

iStock/Thinkstock(NEW YORK) -- Some were warned by a parent before every health care encounter. Some heard it from a doctor. Others remember an uncomfortable reaction. Around one in 10 people are told at some point in their lives that they are allergic to penicillin. Actually having a penicillin allergy, however, is far less common, and carrying the "allergy" label can, in fact, be harmful.

In a new study, researchers showed that, using formal allergy testing, many children with a reported penicillin allergy actually could take penicillin antibiotics without a problem.

Researchers in the pediatric emergency department at the Children’s Hospital of Wisconsin found that 76 percent of children with a penicillin allergy in their medical chart reported only low-risk symptoms, such as rash, vomiting or diarrhea. When 100 children with low-risk symptoms agreed to go through formal allergy testing, all 100 children passed the test -- they didn’t have a penicillin allergy. Then the important part: The allergy label was removed from the medical chart.

Lead author Dr. David Vyles, a pediatric emergency medicine physician at Medical College of Wisconsin and Children's Hospital of Wisconsin, told ABC News, "I have several kids myself. When I was in medical school, one of them was diagnosed with a penicillin allergy." He "never believed the allergy in the first place” because it didn’t fit the symptoms of a true allergy. "When I was paying for medications, there was a huge difference in cost between getting amoxicillin for an ear infection and getting an alternative antibiotic."

When he entered training, he said he realized just how many people think they have a penicillin allergy.

"You're getting 10 percent of [Americans] reporting that they're allergic, and that's causing huge problems down the line," he said. "We thought about how we could make a difference in young kids that could be carried through to adulthood. And that was de-labeling them."

The group published these findings last year. But then they were interested whether such de-labeling would convince the kids' pediatricians to prescribe penicillin antibiotics -- or whether families would be willing to actually take them.

About three-quarters of parents responded that they would feel comfortable with their child receiving penicillin antibiotics after the testing.

In fact, 26 of those 100 children did take a penicillin antibiotic in that year. None of these children had serious reactions, and only one developed even a rash.

Penicillin allergy: what’s the harm?

Many of the most effective antibiotics for common infections are penicillin derivatives. Often, the second-line antibiotics are not only less effective, but more toxic. Alternative antibiotics may be more likely to cause uncomfortable side effects or even adverse events such as kidney damage or a secondary infection. Studies have shown that kids with a penicillin allergy actually end up with longer average hospital stays than their non-allergic peers.

Avoiding penicillin antibiotics also means that providers have to use more powerful antibiotics in settings where they are not necessary. This breeds bacteria resistant to the strong antibiotics, potentially creating dangerous superbugs.

An added benefit: Penicillin drugs are often the least expensive option, so the use of second-line antibiotics for questionable allergies subjects parents such as Dr. Vyles and the health care system at large to higher costs. In this study group alone, the estimated cost savings achieved by getting penicillin antibiotics rather than an alternative were calculated at $1,368. The potential annual savings at the Children’s Hospital of Wisconsin emergency department has been estimated at $192,000.

And they're not stopping there. Vyles and his team are in the middle of a new study -- allergy testing right in the emergency room, with careful documentation of the difference in antibiotic spending in subsequent years.

Penicillin allergy by the numbers

Severe penicillin allergies are extremely rare. Experts estimate that a severe reaction, or anaphylaxis, occurs fewer than five times for every 10,000 times a penicillin medication is prescribed. An anaphylactic reaction happens within one to two hours after a dose and involves hives, facial swelling, difficulty breathing and low blood pressure with dizziness or fainting. Anaphylaxis can develop quickly and can be deadly.

Around 10 percent of people have a penicillin allergy noted in their medical records. But studies in adults have suggested that only around 10 percent of those individuals are actually allergic at all.

Regardless, medical professionals are hesitant to prescribe penicillin or to remove the allergy from the record, even for low-risk symptoms. The mindset is "better safe than sorry." Drug-allergy labels are tough to shake and tend to stay in the person's medical chart, even if they lack supporting information, until providers intentionally remove them and communicate this change to other providers.

Vyles pointed out that around one-fourth of parents in his follow-up survey were hesitant to give their child penicillin antibiotics, despite the child's mild symptoms with the first reaction and despite tests that showed the absence of an allergy.

"There is a stigma with a penicillin allergy when you get it," he said. "It breeds fear. We're going to have to tackle this moving forward."

Why all the mislabeling?

Like many drugs, penicillin antibiotics have side effects, which are simply symptoms related to the drug’s normal actions on the body. The most common side effects of penicillin are rash, diarrhea and nausea, which can be easily misinterpreted as an allergic reaction.

People can also have hypersensitivity reactions or an over-reactive response to a drug. These can look a lot like true allergies, and the best way to differentiate the two is by formal allergy testing. Hypersensitivity reactions can go away over time, so having one in the past does not guarantee the same symptoms the next time someone takes an antibiotic. This is particularly true for children.

An even more common scenario is when an illness itself mimics an allergic response. It is very common for children with viral infections to develop a rash several days into their illness, which is often the same time they receive an antibiotic. The antibiotic, rather than the infection, gets blamed for the rash.

Some children receive the allergy label because their parents have heard that a penicillin allergy is genetic, but it's not.

The most reliable method for drug-allergy testing involves three phases, starting with a skin test and ending with taking the medication under medical supervision. Because of the potential for a dangerous allergic reaction, allergy testing should only be done by a provider with expertise in the field. The time and cost required is one reason patients and providers often don't pursue this testing.

Deciding to get allergy testing, though, could ensure a person has a full range of antibiotic options next time he or she gets sick -- and could save them money as well.

"Anybody who has a penicillin allergy should at least talk to their physician about getting tested for that allergy," Vyles said. "It’s a two-hour process and could make a big difference in their life."

Dr. Kelly Arps is a resident physician in internal medicine at Johns Hopkins Hospital. Kelly is working with the ABC News Medical Unit.

Copyright © 2018, ABC Radio. All rights reserved.


Subscribe To This Feed

iStock/Thinkstock(NEW YORK) -- Anne Wojcicki isn’t a typical CEO.

The 44-year-old mother of two who runs the consumer genetics and research company 23andMe, reportedly valued at over $1 billion, prefers a uniform of Lululemon shorts, bikes to work every day -- unless it’s raining -- and didn’t exactly set out on the executive path.

“I was in college. I didn't know that there were real jobs. I think about how naive I was on the job development process,” Wojcicki says on an episode of ABC Radio’s “No Limits with Rebecca Jarvis” podcast.

Wojcicki says she grew up in an “academic environment.” Her father was the chair of the physics department at Stanford University and her mother, Esther Wojcicki, is a renowned journalism teacher.

Her parents raised three successful daughters: Susan Wojcicki is CEO of YouTub and Dr. Janet Wojcicki is an anthropologist and epidemiologist at UCSF.

Growing up they were taught “to just be curious and to problem solve.”

As a child, Wojcicki loved science and recalls a definitive moment from Kindergarten when she first learned about DNA.

"My sister was talking about genes and I kept staring at her. I was like, 'But you have shorts on,'" she recalled. "It was because they were talking about DNA. And that was the first time I ever heard about DNA and I was fascinated. Absolutely fascinating that there's like this thing inside you and you could discover it."

When it came time to apply for jobs after college, Wojcicki, who studied biology at Yale University, didn’t have a clear idea of what she wanted to do.

“My mom was like, ‘Just interview for a bunch of stuff and see.’ And I very randomly got this job offer for the Wallenberg family in Sweden as an analyst," she said. "I had no idea what it was."

"And I kind of took the job mostly because I wanted to wear Ann Taylor clothing, like I thought it would be fun to dress up,” Wojcicki told Jarvis, laughing at the memory.

She spent nearly a decade working in healthcare investing, focusing primarily on biotechnology companies. She says the information she learned on the job was invaluable.

“In some ways, as an analyst on Wall Street, I couldn't have asked for a better training because here I was at 22 and I had this opportunity to study every single healthcare company out there. I always felt like my 10 years on Wall Street was like getting a Ph.D. and then a postdoc,” Wojcicki said.

She loved some aspects of the job: studying healthcare companies, learning the science behind the work they were doing, and speaking to CEOs and even Nobel Prize winners. But she became disillusioned about the healthcare industry as a whole.

“The big conclusion that I learned was, this was a system that does not reflect what's in my best interest. I loved the research and that element but I also just started to feel like this is a system that was taking advantage of people,” Wojcicki recalls.

Keeping her day job, she began to volunteer in hospitals at night and she saw firsthand how patients struggled with astronomical medical bills. Her tipping point? A conference about insurance reimbursement.

“All these people were at this meeting just to figure out how to optimize billing. How can you bill more for every procedure? And I just realized, I’m done. It was that moment where I was like, 'The system's never going to change from within, [and] so many people make money on the inefficiencies of health care,'" she said. "And I felt like that was the end. I know how the system works. I'm going to try to make a difference.”

Wojcicki left her lucrative career on Wall Street to launch 23andMe, a genetic testing and research company that offers affordable, home-based saliva collection kits to provide customers with access to their genetic information. This includes reports on traits, wellness, carrier status and genetic ancestry.

They also offer customers the option to opt into research participation.

“23andMe was intentionally set out to be very different than every other company I'd ever researched because I wanted to reflect what's in the best interests of the customer, the consumer and to actually try and help people be healthy,” Wojcicki said.

Now 12 years old, 23andMe has built one of the largest databases of individual genetic information and has raised almost $500 million in venture capital funds, according to the company.

But it wasn’t without setbacks. In 2013, the Food and Drug Administration (FDA) demanded that 23andMe stop marketing their kits, citing “potential health consequences” resulting from “false positive or false negative assessments.”

The FDA had classified 23andMe’s Saliva Collection Kit and Personal Genome Service as a “medical device” and claimed it had not been “analytically or clinically validated” for the intended use. Some experts worry that people get the genetic advice without enough interpretation about what to do with the information.

“I always argued we had the right intentions but ... I realize now we didn't know how to communicate," Wojcicki said of the FDA controversy. "So it was a moment, it was definitely a shock.”

Wojcicki became committed to working with the FDA, following their guidelines and, in 2015, 23andMe received authorization for its first genetics test for Bloom syndrome. In 2017, the FDA approved 23andMe's offer of 10 genetic health risk reports, including late-onset Alzheimer’s disease, Parkinson’s disease and celiac disease.

And earlier this year, the company received the first-ever FDA authorization for direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 report.

For Wojcicki, her success and the success of her company is about determination.

“There's very few cases where there's overnight success. We've been working on all of our approvals. Like BRCA ... we've worked on this for years. So sometimes it just takes a lot of work to get something done," she said. "And one thing I advise to entrepreneurs is you have to stick with it. Success comes from actually, like really sticking with it.”

And her advice to those just starting out?

"Everything when you're 22 is interesting. It doesn't matter what job you take. Just take a job where you're going to learn something and then keep learning. And the minute you stop learning get a different job," she advised. "Every job I ever had contributed to who I am today and what I've learned."

Hear more of Anne Wojcicki's interview on "No Limits With Rebecca Jarvis," available on Apple Podcasts, Stitcher, Google Play Music, Spotify, TuneIn and the ABC News app.

Copyright © 2018, ABC Radio. All rights reserved.


LinkedUpRadio Envisionwise Web Services